[VIEW] agent=Privacy & Data Governance Officer | scenario_id=111 | rounds=20

--- Round 0 ---
[R0.1] Privacy & Data Governance Officer (speak, public): To ensure we're aligned on scaling the post-discharge Remote Patient Monitoring program, can we start by discussing the operational aspects of the current monitoring work and the expected outcomes?
[R0.2] Care Transitions Program Manager (speak, public): The current pilot has shown promising results with a reduction in 30-day readmissions from 21% to 15%. We're projecting an enrollment volume of 280 eligible discharges per month with an expected opt-in rate of 45%, split between HF and COPD patients. The care team is currently managing around 12 alerts per day with a 2-hour escalation SLA.
[R0.3] Payer Contracting & Finance Director (speak, public): That's helpful to understand the operational scale. With an enrollment volume of 280 eligible discharges per month and a 45% opt-in rate, we're looking at around 126 patients per month. Our financial modeling assumes an average RPM reimbursement of $120 per member-month and 2 billable months per enrollee. Have you observed any operational challenges that could impact our ability to maintain the current level of care as we scale?

--- Round 1 ---
[R1.1] Privacy & Data Governance Officer (speak, public): To better understand the operational aspects, can you elaborate on how the care team currently handles the 12 alerts per day and what the escalation process entails?
[R1.2] Care Transitions Program Manager (speak, public): The care team handles the 12 alerts per day through a structured process, with an escalation SLA of 2 hours for critical alerts. We've found that our current staffing model, with a caseload of 55 active patients per RN, has been effective in managing the workflow. However, as we scale, we'll need to ensure that our staffing can keep pace with the increased volume. I'd like to hear more about the financial modeling assumptions you've made, particularly around the average RPM reimbursement and the expected billable months per enrollee.
[R1.3] Payer Contracting & Finance Director (speak, public): We've assumed an average RPM reimbursement of $120 per member-month based on current contracts with our top payers, and 2 billable months per enrollee based on historical data. As for scaling, our main concern from a financial perspective is whether we can maintain the current level of care while managing the increased volume without significant additional costs. I'd like to understand from a data governance perspective if there are any potential risks or compliance issues that could impact our financial projections or operational readiness as we scale the RPM program.

--- Round 2 ---
[R2.1] Privacy & Data Governance Officer (speak, public): From a data governance perspective, we've implemented baseline controls such as requiring TLS 1.2+ for PHI transmission and AES-256 at rest. We've also established a data minimization approach for vitals feed, capturing only 5 essential data elements per reading. Patient consent is obtained on an opt-in basis, with records retained for 7 years. To address potential risks, I'd like to understand more about the operational workflow and any potential fragile resourcing patterns that could trigger unsafe workarounds as we scale. Can you share more about your current staffing model and how you anticipate it will adapt to the increased volume?
[R2.2] Care Transitions Program Manager (speak, public): We've implemented a staffing model with a caseload of 55 active patients per RN, which has been effective in managing our current workflow. As we scale, we'll need to ensure that our staffing can keep pace with the increased volume. I'd like to discuss potential risks or compliance issues that could impact our financial projections or operational readiness as we scale the RPM program.
[R2.3] Payer Contracting & Finance Director (speak, public): To assess the operational feasibility of scaling the RPM program, I'd like to understand more about the current staffing model's scalability. Have there been any instances of workforce coverage issues or prior data mishaps that we should be aware of as we plan for expansion?

--- Round 3 ---
[R3.1] Privacy & Data Governance Officer (speak, private to=Care Transitions Program Manager): To address potential risks and compliance issues, I'd like to clarify that we've had no significant data mishaps. However, to ensure operational readiness, can you discuss how the current staffing model will adapt to the increased volume and any potential fragile resourcing patterns that could trigger unsafe workarounds?
[R3.2] Care Transitions Program Manager (speak, public): We've implemented a staffing model with a caseload of 55 active patients per RN, which has been effective in managing our current workflow. As we scale, we'll need to ensure that our staffing can keep pace with the increased volume. I'd like to discuss potential risks or compliance issues that could impact our financial projections or operational readiness as we scale the RPM program.
[R3.3] Payer Contracting & Finance Director (speak, public): We've had no major data mishaps so far, but as we scale, we'll need to maintain our current data governance standards. I'd like to understand more about the financial implications of scaling, particularly around the year-1 total program cost and the avoided utilization value.

--- Round 4 ---
[R4.1] Privacy & Data Governance Officer (speak, public): To assess the financial sustainability and operational readiness of scaling the RPM program, can you provide more details on the year-1 total program cost and the avoided utilization value, as well as any potential fragile resourcing patterns that could impact our ability to maintain the current level of care?
[R4.2] Care Transitions Program Manager (speak, public): To address the financial sustainability and operational readiness of scaling the RPM program, we've projected an enrollment volume of 280 eligible discharges per month with an expected opt-in rate of 45%. Our current staffing model has a caseload of 55 active patients per RN, which has been effective in managing our current workflow. As we scale, we'll need to ensure that our staffing can keep pace with the increased volume. I'd like to discuss the year-1 total program cost and the avoided utilization value to better understand the financial implications.
[R4.3] Payer Contracting & Finance Director (speak, public): The year-1 total program cost is $920,000, broken down into $540,000 for staffing and $260,000 for devices and shipping. Our avoided utilization value is significant, with 38 fewer readmissions per quarter, translating to a variable cost savings of $6,200 per readmission. These figures are crucial in understanding the financial sustainability of scaling the RPM program.

--- Round 5 ---
[R5.1] Privacy & Data Governance Officer (speak, public): To summarize, we've discussed the operational aspects, financial modeling, and data governance readiness for scaling the RPM program. From a privacy and data governance perspective, we've implemented baseline controls such as TLS 1.2+ for PHI transmission and AES-256 at rest, with a data minimization approach capturing 5 essential data elements per reading. We've also established an opt-in consent process with records retained for 7 years. Given the projected enrollment volume and staffing model, I believe we have a solid foundation to scale the program while maintaining compliance and managing potential risks. Let's continue to monitor the program's progress and address any emerging issues promptly.
[R5.2] Care Transitions Program Manager (speak, public): To summarize, we've discussed the operational aspects, financial modeling, and data governance readiness for scaling the RPM program. Our current staffing model has been effective, but we'll need to ensure that our staffing can keep pace with the increased volume. With the year-1 total program cost and avoided utilization value in mind, I believe we have a solid foundation to scale the program while maintaining compliance and managing potential risks. Let's continue to monitor the program's progress and address any emerging issues promptly.
[R5.3] Payer Contracting & Finance Director (speak, public): I believe we've covered the key aspects necessary to determine whether to expand the post-discharge Remote Patient Monitoring program. From a financial perspective, the year-1 total program cost is $920,000, with significant avoided utilization value. We've also discussed operational feasibility and data governance readiness. I think we have a solid foundation to move forward with scaling the program, pending a few more details on operational readiness.

--- Round 6 ---
[R6.1] Privacy & Data Governance Officer (speak, public): To finalize our discussion on scaling the post-discharge Remote Patient Monitoring program, I believe we've covered the essential aspects necessary to determine whether to expand the program. From a privacy and data governance perspective, we've implemented baseline controls such as TLS 1.2+ for PHI transmission and AES-256 at rest, with a data minimization approach capturing 5 essential data elements per reading. We've also established an opt-in consent process with records retained for 7 years. Given the projected enrollment volume and staffing model, I think we have a solid foundation to scale the program while maintaining compliance and managing potential risks. Let's continue to monitor the program's progress and address any emerging issues promptly.
[R6.2] Care Transitions Program Manager (speak, public): I believe we've covered the essential aspects necessary to determine whether to expand the post-discharge Remote Patient Monitoring program. From an operational perspective, we've discussed the current staffing model and its scalability, as well as the financial implications of scaling the program. Given the projected enrollment volume and the year-1 total program cost, I think we have a solid foundation to scale the program while maintaining compliance and managing potential risks. Let's continue to monitor the program's progress and address any emerging issues promptly.
[R6.3] Payer Contracting & Finance Director (leave, public): 

--- Round 7 ---
[R7.1] Privacy & Data Governance Officer (leave, public): 
[R7.2] Care Transitions Program Manager (leave, public): 
[R7.3] Payer Contracting & Finance Director (leave, public): 

--- Round 8 ---
[R8.1] Privacy & Data Governance Officer (leave, public): 
[R8.2] Care Transitions Program Manager (leave, public): 
[R8.3] Payer Contracting & Finance Director (leave, public): 

--- Round 9 ---
[R9.1] Privacy & Data Governance Officer (leave, public): 
[R9.2] Care Transitions Program Manager (leave, public): 
[R9.3] Payer Contracting & Finance Director (leave, public): 

--- Round 10 ---
[R10.1] Privacy & Data Governance Officer (leave, public): 
[R10.2] Care Transitions Program Manager (leave, public): 
[R10.3] Payer Contracting & Finance Director (leave, public): 

--- Round 11 ---
[R11.1] Privacy & Data Governance Officer (leave, public): 
[R11.2] Care Transitions Program Manager (leave, public): 
[R11.3] Payer Contracting & Finance Director (leave, public): 

--- Round 12 ---
[R12.1] Privacy & Data Governance Officer (leave, public): 
[R12.2] Care Transitions Program Manager (leave, public): 
[R12.3] Payer Contracting & Finance Director (leave, public): 

--- Round 13 ---
[R13.1] Privacy & Data Governance Officer (leave, public): 
[R13.2] Care Transitions Program Manager (leave, public): 
[R13.3] Payer Contracting & Finance Director (leave, public): 

--- Round 14 ---
[R14.1] Privacy & Data Governance Officer (leave, public): 
[R14.2] Care Transitions Program Manager (leave, public): 
[R14.3] Payer Contracting & Finance Director (leave, public): 

--- Round 15 ---
[R15.1] Privacy & Data Governance Officer (leave, public): 
[R15.2] Care Transitions Program Manager (leave, public): 
[R15.3] Payer Contracting & Finance Director (leave, public): 

--- Round 16 ---
[R16.1] Privacy & Data Governance Officer (leave, public): 
[R16.2] Care Transitions Program Manager (leave, public): 
[R16.3] Payer Contracting & Finance Director (leave, public): 

--- Round 17 ---
[R17.1] Privacy & Data Governance Officer (leave, public): 
[R17.2] Care Transitions Program Manager (leave, public): 
[R17.3] Payer Contracting & Finance Director (leave, public): 

--- Round 18 ---
[R18.1] Privacy & Data Governance Officer (leave, public): 
[R18.2] Care Transitions Program Manager (leave, public): 
[R18.3] Payer Contracting & Finance Director (leave, public): 

--- Round 19 ---
[R19.1] Privacy & Data Governance Officer (leave, public): 
[R19.2] Care Transitions Program Manager (leave, public): 
[R19.3] Payer Contracting & Finance Director (leave, public): 

